Endovascular Treatment for Cerebral Venous Sinus Thrombosis: Comparison among Different Endovascular Procedures

医学 血管内治疗 脑静脉窦血栓形成 静脉血栓形成 血栓形成 放射科 外科 动脉瘤
作者
Anush Rangarajan,Dileep Ramachandran,Trinath Kumar Mishra,Vidhya Gunaseelan,Gopal Krishna Dash,Vivek Jacob Philip,Radhika Manohar,Kuldeep Shetty,Pavin Thomas,Vikram Huded
出处
期刊:Annals of Indian Academy of Neurology [Medknow Publications]
卷期号:27 (2): 140-145
标识
DOI:10.4103/aian.aian_965_23
摘要

Background: Cerebral venous sinus thrombosis (CVST) is a rare, treatable cause of stroke. Even though CVST has an established medical treatment, 15% of patients remain refractory to treatment. These patients may be candidates for endovascular treatment (EVT), yet the selection of patients remains a challenge. The study aims to understand the profile and outcome of patients treated with EVT and the type of procedure associated with good outcomes. Methods: This is a single-center, retrospective analysis of CVST patients who underwent EVT from 2009 till 2022. Patients who received only medical management were excluded. Modified Rankin Scale (mRS) ≤2 at 3 months was taken as the primary outcome. Secondary outcomes assessed were hospital stay, death, recurrence, mRS ≤ 2 at discharge, and angiographic recanalization. Results: Fifty-two patients were included. Twenty-eight (53.8%) were males; the mean age was 33.3 ± 12.3 years. Headache ( n = 44, 84.6%) predominated among the symptoms. The common risk factors were anemia ( n = 13, 25.5%) and hyperhomocysteinemia ( n = 13, 25.5%). Worsening of sensorium ( n = 21, 40.3%) and non-improvement of symptoms ( n = 15, 28.8%) were the common indications for the procedure. Twenty-five (48.1%) people underwent in situ thrombolysis (IST). Death occurred in eight (15.3%) patients. Thirty-six (73.5%; 36/49) patients had a good outcome at 3 months. IST had a significantly better outcome (mRS ≤ 2, n = 20, 80%) compared to other procedures ( P = 0.04). Hospital stay was lesser in the IST subgroup, but without statistical significance. Midline shift >5 mm (odds ratio [OR] 6.8 [1.5–30.9], P = 0.01) and Glasgow Coma Scale <9 before the procedure (OR 27.2 [3.1–236.4], P = 0.002) predicted bad outcomes at 3 months. Female gender (OR 4.5 [1.07–8.8], P = 0.03), presence of altered sensorium (OR 10.2 [1.2–87.5], P = 0.01), encephalopathic syndrome ( P = 0.02), presence of parenchymal bleed (OR 3.7 [0.9–4.5], P = 0.04), and midline shift (OR 4.8 [1.1–20.2], P = 0.03) were associated with poor outcome at discharge. Conclusion: EVT yielded good outcomes in carefully selected, medically refractory patients of CVST. IST performed well compared to other procedures.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小马想毕业完成签到,获得积分10
1秒前
橙子发布了新的文献求助10
1秒前
Wt完成签到 ,获得积分10
1秒前
胆XIAOXING完成签到,获得积分10
2秒前
懵懂的土豆完成签到,获得积分10
2秒前
3秒前
4秒前
4秒前
6秒前
谷策完成签到,获得积分10
6秒前
忧郁凌波发布了新的文献求助10
6秒前
明天过后完成签到,获得积分10
6秒前
战善完成签到,获得积分10
7秒前
7秒前
杨e关注了科研通微信公众号
8秒前
所所应助cbbb采纳,获得10
8秒前
天天快乐应助Sunshine采纳,获得10
8秒前
8秒前
FashionBoy应助seven采纳,获得10
9秒前
谷策发布了新的文献求助10
9秒前
Jasper应助Nancy采纳,获得10
9秒前
科目三应助小犬采纳,获得10
9秒前
Fiona发布了新的文献求助10
9秒前
酸奶球完成签到 ,获得积分10
11秒前
科研小白鼠关注了科研通微信公众号
11秒前
情怀应助科研通管家采纳,获得10
11秒前
大模型应助Yv采纳,获得10
12秒前
Orange应助科研通管家采纳,获得10
12秒前
CipherSage应助科研通管家采纳,获得10
12秒前
科研通AI2S应助科研通管家采纳,获得10
12秒前
充电宝应助科研通管家采纳,获得10
12秒前
小白发布了新的文献求助20
12秒前
cc发布了新的文献求助10
13秒前
13秒前
研友_LB3vXn完成签到,获得积分20
14秒前
FashionBoy应助风中天奇采纳,获得10
14秒前
wj完成签到,获得积分10
15秒前
如果多年后完成签到 ,获得积分10
15秒前
段段完成签到,获得积分10
17秒前
liyang发布了新的文献求助10
18秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3148271
求助须知:如何正确求助?哪些是违规求助? 2799495
关于积分的说明 7834708
捐赠科研通 2456632
什么是DOI,文献DOI怎么找? 1307357
科研通“疑难数据库(出版商)”最低求助积分说明 628154
版权声明 601655